Amifostine and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

NCT00003268 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Drug/Agent Toxicity by Tissue/Organ
Leukemia

Interventions

DRUG: amifostine trihydrate
DRUG: cytarabine
DRUG: idarubicin

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University